Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001244341 | SCV001417553 | uncertain significance | not provided | 2021-08-20 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine with arginine at codon 793 of the ELP1 protein (p.Thr793Arg). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004034776 | SCV004864135 | uncertain significance | not specified | 2023-11-27 | criteria provided, single submitter | clinical testing | The c.2378C>G (p.T793R) alteration is located in exon 23 (coding exon 22) of the IKBKAP gene. This alteration results from a C to G substitution at nucleotide position 2378, causing the threonine (T) at amino acid position 793 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001835201 | SCV002082083 | uncertain significance | Familial dysautonomia | 2020-04-20 | no assertion criteria provided | clinical testing |